期刊文献+

危重病患者菌血症75例分析 被引量:8

Analysis of critically ill patients with bacteremia
原文传递
导出
摘要 目的了解危重病患者菌血症的流行病学概况和死亡的危险因素,并对抗生素治疗进行评估。方法对1989~1996年间北京协和医院加强医疗病房75例危重病患者发生的116次菌血症进行回顾性分析。结果菌血症患者的病死率43%。致病菌多为高度耐药的病原菌,如葡萄球菌(29%)、肠球菌(12%)、产I型诱导酶的肠杆菌(12%)和产超广谱酶的肠杆菌(10%)。其中革兰阳性球菌检出率较高。受累脏器按呼吸(77%)、肝脏(53%)、循环(53%)、消化道(50%)、肾脏(47%)、中枢神经(36%)和血液系统(27%)依次减少。其中多器官功能衰竭为76%。单因素分析显示原发病严重程度、多器官功能衰竭、感染性休克、肝功能衰竭、肾功能衰竭以及感染灶部位均显著影响患者的死亡(P<0.05)。Cox比例风险模型分析提示中枢神经系统功能衰竭、感染性休克、血液系统功能衰竭、肝功能衰竭和呼吸道操作均显著影响菌血症患者的生存时间。结论革兰阳性球菌是危重病患者菌血症的重要致病菌。抗生素治疗不能预防菌血症,亦不能改变菌血症患者的预后。 Objective To study the epidemiology of bacteremia of critically ill patients and the mortality associated with bacteremia and risk factors for death in an intensive care unit. Method 75 patients with 116 episodes of bacteremia were retrospectively studied. Results The mortality rate of the patients was 43%. Staphylococci (29%), Enterococci (12%), Class I inducible β lactamase producing Enterobacter (12%), extensive spectrum β lactamase producing Enterobacter (10%) were the most common pathogens, among which gram positive organisms constitute a major part. The most commonly affected organs were respiratory (77%), hepatic (53%), circulatory (53%), gastrointestinal (50%), renal (47%), central nervous (36%),and hemopoietic systems (27%). Multiple organ failure accounted for 76%. Univariate analysis revealed that the severity of underlying illness, multiple organ failure (MOF), septic shock, hepatic failure, renal failure and infection focus were the risk factors for in hospital death ( P <0.05)。Cox proportional hazard model analysis suggested central nervous system failure, septic shock, hemopoietic failure, hepatic failure and respiratory manipulation significantly affected the survival time of patients with bacteremia ( P <0.05). Conclusion Gram positive organisms are major pathogens of bacteremia in critically ill patients. Antibiotic therepy can not prevent the occurence of bacteremia, nor can it improve the prognosis.
出处 《中华医学杂志》 CAS CSCD 北大核心 1998年第6期416-419,共4页 National Medical Journal of China
关键词 菌血症 死亡率 危险因素 危重病 Bacteremia Hospital mortality Risk factor
  • 相关文献

参考文献1

  • 1杜斌,中华医学杂志,1996年,76卷,262页

同被引文献39

  • 1周贵民,张有江,张淑兰,许淑珍,张秀珍,宣天芝,陈民钧,徐英春.北京4家医院对常用较新的16种抗生素的敏感性监测[J].中华微生物学和免疫学杂志,1995,15(4):219-224. 被引量:76
  • 2杜斌,陈德昌,刘大为,徐英春,谢秀丽,陈民钧.综合性加强医疗病房的获得性细菌感染[J].中华医学杂志,1996,76(4):262-266. 被引量:39
  • 3[10]Nagino K,Kobayashi H.Influence of macrolides′on mucoid alginate biosy nthetic enzyme from Pseudomonas aeruginosa[J].Clin Microbiol Infect,1997,3(4 ):432-439.
  • 4Ohgaki N. Bacterial biofilm in chronic airway infection[J].Kansen Shogaku-Zasshi, 1994, 68(1):138-151.
  • 5Ichimiya T, Yamasaki T, Nasu M. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilms formation[J]. J Antimicrob Chemother, 1994, 34(3):331-341.
  • 6Nagino K, Kobayashi H. Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginos[J]. Clin Microbiol Infect, 1997, 3(4): 432-439.
  • 7董培红,李骥,张慧芳,张友才,王邦松.铜绿假单胞菌的临床分布和耐药性变迁[J].中国微生态学杂志,2007,19(5):452-454. 被引量:26
  • 8David Greenwood, Richardc B Slack, Johu F Peutherer. Medical Microbiology [ M ]. 15th ed. Beijing: Science Press, 1999: 644 ~645.
  • 9 1,Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis andorgan failure and guidelines for the use of innovative therapies in sepsis.Chest,1992,101():1644-1655
  • 10 2,Knaus WA,Draper EA,Wagner DP,et al.APACHE Ⅱ:A sev-erity of diseaseclassification system.Crit Care Med,1985,13(10):818-829 3,Bernard GR,Artigas A,Brigham KL,et al.Report of the American-Europeanconsensus conference on ARDS:Definitions,mechanisms,relevant outcomes and clinicaltrial coordination.Intensive Care Medicine,1994,20(2):225-232

引证文献8

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部